Stephanie Ng

Title: The Innovative Contributions of Stephanie Ng

Introduction

Stephanie Ng is a prominent inventor based in Palo Alto, CA. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target critical pathways in cancer treatment. Her work exemplifies the intersection of innovation and practical application in the medical field.

Latest Patents

Stephanie holds a patent for "Benzoxazepines as inhibitors of PI3K/mTOR and methods of their use and manufacture." This invention is directed to compounds of Formula I and pharmaceutically acceptable salts or solvates thereof. It also includes methods of making and using these compounds, showcasing her commitment to advancing therapeutic options.

Career Highlights

Stephanie is currently employed at Exelixis, Inc., a company known for its focus on developing innovative cancer therapies. Her role at Exelixis allows her to contribute to groundbreaking research and development efforts in the pharmaceutical industry. With her expertise, she plays a vital role in the advancement of new treatment modalities.

Collaborations

Throughout her career, Stephanie has collaborated with notable colleagues, including Neel Kumar Anand and Charles M Blazey. These partnerships highlight the importance of teamwork in driving innovation and achieving significant breakthroughs in research.

Conclusion

Stephanie Ng's contributions to the field of pharmaceuticals through her innovative patents and collaborative efforts underscore her impact on cancer treatment advancements. Her work continues to inspire future innovations in the industry.